NCT07267364 Pelvic Floor Muscle Training and Dynamic Neuromuscular Stabilization Exercises in Pediatric Patients
| NCT ID | NCT07267364 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Necmettin Erbakan University |
| Condition | Urology |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-11-11 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2025-11-11 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Dysfunctional voiding (DY) is one of the most common conditions in children. Various treatments are available. Participants will be randomly assigned to either PFMT (Group I) or PFMT+DNS (Group II). PFMT is the gold standard and routinely administered in hospitals for children diagnosed with dysfunctional voiding who are referred by a urologist. The PFMT group serves as the control group, and treatment will be scheduled for a total of 10 weeks, three days a week. During PFMT, children receive instruction about the pelvic floor using video visuals and increase awareness of their pelvic floor muscles. They are then instructed on how to contract and relax their muscles to control urination. DNS training is an exercise model that begins with spinal stabilization and addresses muscle synergies. Patients included in the study will be evaluated twice, at the beginning and at the end of the treatment: Voiding Disorders Symptom Score (VODS), Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0), Pediatric Incontinence Questionnaire (PIN-Q), Bladder Bowel Dysfunction Scale (BDS), Bristol gaita scale, and Children's Body Image Scale.
Eligibility Criteria
Inclusion Criteria: * Having been diagnosed with voiding dysfunction according to ICCS diagnostic criteria in a urology outpatient clinic, * Being 5-18 years old, * The child and their parent/guardian agree to participate in the study voluntarily and provide signed consent. Exclusion Criteria: * Organic pathologies such as urethral obstruction, ectopic ureter, spinal dysraphism, and diabetes * Diagnosis of VUR or neurogenic bladder * Cognitive and mental impairment * Having spina bifida * Being under 5 years of age * Receiving treatment such as PTC training or electrical stimulation
Frequently Asked Questions
Who can join the NCT07267364 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 18 Years, studying Urology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07267364 currently recruiting?
Yes, NCT07267364 is actively recruiting participants. Visit ClinicalTrials.gov or contact Necmettin Erbakan University to inquire about joining.
Where is the NCT07267364 trial being conducted?
This trial is being conducted at Konya, Turkey (Türkiye), Konya, Turkey (Türkiye).
Who is sponsoring the NCT07267364 clinical trial?
NCT07267364 is sponsored by Necmettin Erbakan University. The trial plans to enroll 48 participants.